Micro Emerging Active

PFE TALZENNA Phase 3 Results

New narrative with limited coverage — still forming.

スコア
0.3
勢い
▲ 0.0
記事
2
情報源
1

Sentiment Timeline

Event Timeline

3月 28, 2026
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data Bullish
3月 27, 2026
Pfizer Inc. (PFE) Announces Positive Topline Results From Phase 3 TALAPRO-3 Study … Neutral

タイムライン

初回検出3月 27, 2026
最終更新3月 27, 2026